Who Regulates Compounding?
State boards of pharmacy—not the FDA—are “typically” asked to regulate compounding practices. However, in light of several tragedies, the FDA has recently been aggressive in asserting its jurisdiction over compounding pharmacies and has issued several 483s and brought court orders against compounding pharmacies. Unlike state agencies, who are often more interested in administrative issues, the FDA aggressively reviews for quality concerns.
It is likely that in the coming days, the jurisdiction will change and the FDA will gain significant oversight over pharmacies.
Preparing for Inspections
The Kulkarni Law Firm can help you prepare for FDA inspections. With a proper plan in place, you may be able to avoid harsh punishments, such as warning letters, fines, or even a complete shut-down.
Disclaimer: The material on our website has been prepared and published for informational purposes only. There is no effort or intention to solicit new clients or new engagements from existing clients by way of this website, nor should any of the information published on the website be construed as representing any of our lawyers' availability to practice in jurisdictions where they are not authorized to do so.
None of these materials are offered, nor should be construed, as legal advice. Communication of information by or through this website and your receipt or use of such information is not intended to create an attorney-client relationship with the Kulkarni Law Firm, P.C. or any of the Firm's attorneys. The creation of the attorney-client relationship would require direct, personal contact between you and the Firm through one or more attorneys and would also require an explicit agreement by the Firm that confirms that an attorney-client relationship is established and the terms of that relationship. You should not act or rely on information contained in these materials without specifically seeking professional legal advice.